Future Outlook of the Infectious Disease Diagnostics Testing Market: Growth, Trends, and Emerging Opportunities Explored
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the infectious disease diagnostics testing market size evolved in recent years?
The market size of infectious disease diagnostics testing has seen a significant expansion recently. The growth starts from $38.52 billion in 2024 and is projected to reach $42.56 billion in 2025 at a CAGR of 10.5%. Factors that contributed to this historic period of growth include increasing occurrences of disease outbreaks like SARS, Ebola, and Zika, heightened awareness among healthcare specialists and the public about the need for early detection and prevention of such diseases, and rising government-backed initiatives to oversee, manage, and prevent diseases. A surge in global travel and commerce has also facilitated the dissemination of infectious diseases, alongside increased healthcare expenditures especially in developing economies.
What are the predictions for the infectious disease diagnostics testing market size in the coming years?
Expectations are high for swift upsurge in the infectious disease diagnostics testing market size over the next few years, with predictions suggesting it’ll escalate to $62.58 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%. The anticipated growth during the forecast period is due to consistent emergence of new pathogens like new influenza strains or COVID-19, the shift towards personalized medicine and targeted therapies, the increasing requirement for prompt and on-site testing solutions, an all-time high emphasis on disease surveillance and early warning systems, and significant research and development activities for creating novel diagnostic technologies and biomarkers. Pivotal trends for the forecast period encompasses miniaturization and portability of diagnostic devices, the uptake of multiplex assays that can concurrently identify many pathogens, incorporation of digital health technologies such as mobile applications and telemedicine platforms, the employment of next-generation sequencing (NGS) technologies for diagnosis of infectious diseases, advancements in rapid and sensitive detection technologies for infectious agents, and the amalgamation of Artificial Intelligence and machine learning algorithms into diagnostic platforms.
Get your infectious disease diagnostics testing market report here!
What key factors are fueling the growth of the infectious disease diagnostics testing market?
The infectious disease diagnostic testing market is predicted to grow due to an anticipated increase in respiratory infections. Such infections affect parts of the respiratory system like the nose, throat, airways, and lungs. The rise in these infections is attributed to many factors such as close contact with people who are already infected, poor sanitation, densely populated residential areas, and seasonal weather changes. Utilizing infectious disease diagnostic tests is crucial for accurate detection and treatment of these infections, as these tests can correctly identify the presence of pathogens like bacteria and viruses in patients’ samples. For instance, data from the Canadian Institute for Health Information, a non-profit organization based in Canada, showed that there was a 32% increase in hospital admissions due to acute upper respiratory infections, from 2,114 cases in 2022 to 2,797 cases in 2023 in February 2024. Thus, the escalation in respiratory infections is fueling the growth of the infectious disease diagnostic testing market.
How is the global infectious disease diagnostics testing market divided into key segments?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
Who are the key firms paving the way for growth in the infectious disease diagnostics testing market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
What are the key trends shaping the future of the infectious disease diagnostics testing market?
Leading firms participating in the infectious disease diagnostic testing market are placing a high emphasis on developing cutting-edge innovations like molecular diagnostic platforms. These are complex systems created to identify and study nucleic acids (DNA or RNA) derived from biological samples for diagnostic objectives. For instance, in May 2022, Becton Dickinson and Company, a medical technology entity based in the US, unveiled the BD COR System. This system is a fully automated, high-throughput platform for molecular diagnostics of infectious diseases. It streamlines and automates the entire molecular laboratory process, from handling samples to generating diagnostic outcomes, making manual specimen sorting unnecessary and liberating laboratory technicians for more important assignments. The system has the capacity to handle up to 1,700 samples and can provide results within a 24-hour time frame, demonstrating its high-throughput prowess and advanced genotyping for diseases like HPV and STIs.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831
What regions are contributing significantly to the growth of the infectious disease diagnostics testing market?
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
PCR And Realtime PCR Testing Global Market Opportunities And Strategies To 2030: COVID-19 Implication And Growth
https://www.thebusinessresearchcompany.com/report/pcr-and-rt-pcr-testing
Pharmaceutical Sterility Testing Global Market Report 2024
Prenatal Testing & Newborn Screening Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
